Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
Tae Sun Shim
Intest Res. 2014;12(1):12-19.   Published online 2014 Jan 28     DOI: https://doi.org/10.5217/ir.2014.12.1.12
Citations to this article as recorded by Crossref logo
Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario
Alok Kumar Mantri, Priti Meena, Amarender Singh Puri, Ajay Kumar, Sanjeev Sachdeva, Siddharth Srivastava, K. Arivarasan, Shivakumar Varakanahali, Jos R. Lapa e Silva
Tuberculosis Research and Treatment.2021; 2021: 1.     CrossRef
Risk stratification and management of QuantiFERON-positive solid-organ living donors
Jean Gibb, Darren Wong
Current Opinion in Organ Transplantation.2020; 25(4): 351.     CrossRef
Variations of tuberculin skin test in patients with rheumatologic disorders and under anti-TNF treatment
Tayfun Özdemir, Serpil Tuna, Özlem Karataş, Mehmet İhsan Arman
Journal of Surgery and Medicine.2019;[Epub]     CrossRef
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef
A Surprising Granulomatous Cheilitis
Chloé Charpentier, Diane Kottler, Charlotte Fite, Anne-Laure Pelletier, Lydia Deschamps, Vincent Descamps
Gastroenterology.2018; 154(5): 1239.     CrossRef
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
Intestinal Research.2018; 16(1): 17.     CrossRef
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
Journal of Gastroenterology and Hepatology.2018; 33(1): 30.     CrossRef
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
Intestinal Research.2018; 16(1): 4.     CrossRef
Second Korean guidelines for the management of ulcerative colitis
Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
Intestinal Research.2017; 15(1): 7.     CrossRef
Second Korean Guideline for the Management of Ulcerative Colitis
Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease
Shi-xue Dai, Hong-xiang Gu, Qian-yi Lin, Yan-kun Wu, Xiao-yan Wang, Shao-zhuo Huang, Tiao-si Xing, Min-hua Chen, Qing-fang Zhang, Zhong-wen Zheng, Wei-hong Sha
Medicine.2017; 96(26): e7247.     CrossRef
Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
Cândida Abreu, Joana Afonso, Cláudia Camila Dias, Rogério Ruas, António Sarmento, Fernando Magro
Journal of Crohn's and Colitis.2017; 11(10): 1223.     CrossRef
Association between TNF -308G/A polymorphism and susceptibility to pulmonary tuberculosis in the Lur population of Iran
Farhad Shahsavar, Ali Mohammad Varzi, Alireza Azargoon
Asian Pacific Journal of Tropical Biomedicine.2016; 6(1): 80.     CrossRef
Differences in Clinical Manifestations according to the Positivity of Interferon-γ Assay in Patients with Intestinal Tuberculosis
Hye Jin Jung, Young-Ho Kim, You Sun Kim, Seong Yeon Jeong, Sung Won Park, Ji Yeon Seo, Hyemi Jung, Jong Pil Im, Ji Won Kim, Sung Noh Hong, Kuk Lae Lee
Gut and Liver.2016; 10(4): 649.     CrossRef
Reactivation tuberculosis: role of surveillance
Andrew R. DiNardo, Elizabeth Guy
Expert Review of Anti-infective Therapy.2016; 14(5): 501.     CrossRef
Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
Jatinderpal Singh, Amarender S Puri, Sanjeev Sachdeva, Puja Sakhuja, Kulandaivelu Arivarasan
Intestinal Research.2016; 14(2): 183.     CrossRef
Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
Jang Wook Lee, Chang Hwan Choi, Ji Hoon Park, Jeong Wook Kim, Sang Bum Kang, Ja Seol Koo, Young-Ho Kim, You Sun Kim, Young Eun Joo, Sae Kyung Chang
Intestinal Research.2016; 14(2): 146.     CrossRef
How Should We Manage Latent Tuberculosis Infection in Patients Receiving Anti-TNF-α Drugs: Literature Review
Hamid Reza Naderi, Fereshte Sheybani, Susan Rezaei Pajand
Iranian Red Crescent Medical Journal.2016;[Epub]     CrossRef
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
Chang Hwan Choi, In Do Song, Young-Ho Kim, Ja Seol Koo, You Sun Kim, Joo Sung Kim, Nayoung Kim, Eun Soo Kim, Jae Hak Kim, Ji Won Kim, Tae Oh Kim, Hyun Soo Kim, Hyo Jong Kim, Young Sook Park, Dong Il Park, Soo Jung Park, Hyun Joo Song, Sung Jae Shin, Suk-K
Yonsei Medical Journal.2016; 57(6): 1376.     CrossRef
Infektiöse Komplikationen der immunsuppressiven Therapie
T. Feldkamp, O. Witzke
Der Nephrologe.2015; 10(1): 38.     CrossRef
Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
Intestinal Research.2015; 13(3): 213.     CrossRef
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
Bruno Rafael Ramos de Mattos, Maellin Pereira Gracindo Garcia, Julia Bier Nogueira, Lisiery Negrini Paiatto, Cassia Galdino Albuquerque, Caique Lopes Souza, Luís Gustavo Romani Fernandes, Wirla Maria da Silva Cunha Tamashiro, Patricia Ucelli Simioni
Mediators of Inflammation.2015; 2015: 1.     CrossRef
Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy
Tae Sun Shim
Tuberculosis and Respiratory Diseases.2014; 76(6): 261.     CrossRef